packageTepotinib

tepotinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tepotinib is a kinase inhibitor used to treat non-small-cell lung cancer. It is authorised in the European Union for this indication.

Summary written by glm-5.3-flash from Wikidata Q27088961 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tepotinib
ATC codes:L01EP02, L01EX21
DrugBank:DB15133
PubChem CID:25171648
Wikidata:Q27088961
formula:C29H28N6O2
molar mass:492.583 g/mol (PubChem CID 25171648)
logP:3.4 (Drugs.Common 25.09, not verified)

Metabolites

MSC2571109AMSC2571109Amolar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
MSC2571109Ametabolite: MSC2571109A